SCHEMBL2895138

SCHEMBL2895138

CCc1cc(-c2ccc(F)cc2F)ccc1S(=O)(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
USP2 O75604 1/20 0.46
ALDH1A1 P00352 1/20 0.46
DHFR P00374 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
LMNA P02545 1/20 0.46
TTR P02766 1/20 0.46
ALB P02768 1/20 0.46
HMGB1 P09429 1/20 0.46
HPGD P15428 1/20 0.46
CXCL12 P48061 1/20 0.46
KMT2A Q03164 1/20 0.46
HIF1A Q16665 1/20 0.46
SLC22A6 Q4U2R8 1/20 0.46
ACMSD Q8TDX5 1/20 0.46
HSD17B10 Q99714 1/20 0.46
ALOX5AP P20292 7/20 0.41
FEN1 P39748 7/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2236899 0.85 KDM4E (0.46) KDM4EMEN1USP2ALDH1A1DHFR
SCHEMBL13028661 0.81 ALOX5AP (0.48) MEN1ALDH1A1LMNAKMT2AALOX5AP
SCHEMBL13652987 0.80 TTR (0.60) KDM4EMEN1USP2ALDH1A1DHFR
SCHEMBL2193142 0.77 ALOX5AP (0.56) ALOX5APFEN1
SCHEMBL2193138 0.77 ALOX5AP (0.56) ALOX5APFEN1
SCHEMBL12446733 0.76 KDM4E (0.45) KDM4EMEN1USP2ALDH1A1DHFR
SCHEMBL1711828 0.76 PTGS2 (0.50) KDM4EMEN1USP2ALDH1A1DHFR
SCHEMBL795339 0.74 AKR1B1 (0.46) ALDH1A1
SCHEMBL780394 0.74 ALDH1A1 (0.42) MEN1ALDH1A1HPGDKMT2APTGS2
SCHEMBL28689298 0.73 PTGS2 (0.45) KDM4EMEN1ALDH1A1KMT2APTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137141-B1 BIPHENYL-4-YL-SULFONIC ACID ARYLAMIDES AND THEIR USE AS THERAPEUTIC AGENTS UNIV ABERDEEN (GB) 2015-12-02 EP disclosed
US-8524778-B2 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents PIMCO 2664 LIMITED (GB) 2013-09-03 US disclosed
US-20100286266-A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286266-A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents ARSA, SOST, AHR KDM4E 937/4885MEN1 4647/4885USP2 1640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.